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Osteoarthritis (OA) is a major health burden of our time. Age is the most prominent risk factor for the development and
progression of OA. The mechanistic inﬂuence of aging on OA has diﬀerent facets. On a molecular level, matrix proteins such as
collagen or proteoglycans are modiﬁed, which alters cartilage function. Collagen cross-linking within the bone results in impaired
plasticity and increased stiﬀness. Synovial or fat tissue, menisci but also ligaments and muscles play an important role in the
pathogenesis of OA. In the elderly, sarcopenia or other causes of muscle atrophy are frequently encountered, leading to a decreased
stability of the joint. Inﬂammation in form of cellular inﬁltration of synovial tissue or subchondral bone and expression of
inﬂammatory cytokines is more and more recognized as trigger of OA. It has been demonstrated that joint movement can exhibit
anti-inﬂammatory mechanisms. Therefore physical activity or physiotherapy in the elderly should be encouraged, also in order to
increase the muscle mass. A reduced stem cell capacity in the elderly is likely associated with a decrease of repair mechanisms of
the musculoskeletal system. New treatment strategies, for example with mesenchymal stem cells (MSC) are investigated, despite
clear evidence for their eﬃcacy is lacking.
1.Introduction
Half of all persons aged over 65 suﬀer from osteoarthritis
(OA) [1]. As a matter of fact, age is the most prominent risk
factor for the initiation and progression of OA. The common
explanation for this is the cumulative eﬀect of mechanical
loadovertheyears,resultingclinicallyin“wearandtear”and
pathologically in cartilage breakdown [2]. Therefore, OA has
been regarded as a naturally occurring, irreversible disorder,
rather than a speciﬁc, potentially treatable disease. During
the last decade, however, it became clearer that OA is not
a purely mechanical problem. Inﬂammatory and metabolic
processes are substantially involved in the pathogenesis and
progression of OA. Not only cartilage, but also subchondral
bone, menisci, muscles as well as fat, and synovial tissues
play an important role, notably in the early phase of OA
(Figure 1). Therefore, OA has been referred to as a “whole
joint disease.” Despite a higher complexity, this concept has
not only improved our understanding of the disease but also
indicates potentially new treatment strategies.
Tounderstandwhyagingpredisposestothedevelopment
of OA, a link between aging processes and the pathological
changes in the OA joint needs to be established. On a mole-
cular level, aging research has revealed intrinsic changes in
the structure of extracellular matrix proteins such as col-
lagen or proteoglycans. Stiﬀening of the collagen network or
increased glycation provoke a functional impairment of car-
tilage and joint function [3]. Aging also has profound eﬀects
on cellular processes notably leading to enhanced apopto-
sis and reduced cellular regeneration [4].
Nonenzymaticcollagencross-linkingleadsabnormalities
in bone toughness and stiﬀness. Bone plasticity is further
suppressed by an increase of osteon density, which leads to
a lower potency of crack-bridging mechanisms [5].
Synovitis is frequently involved in OA, notably in the
early phase of the disease [6]. This has been demonstrat-
ed both by histological studies and magnetic resonance
imaging (MRI) analyses [7]. OA synovial ﬂuid contains
proinﬂammatory cytokines. This is demonstrated clinically
when a ruptured baker cyst leads to painful swelling of2 Journal of Aging Research
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Figure 1: Osteoarthritis as a whole joint disease in the elderly.
the surrounding soft tissue. Similarly, the penetration of
synovial ﬂuid into the subchondral space after microfracture
of the subchondral bone plate can induce an inﬂammatory
response.
The exact reason for the inﬂamed status of the OA joint
remains unclear. Overuse can lead to an activation of oste-
oblasts but also mast cells. Subsequently, other immune
cells of the innate or adaptive immune system are attracted.
Crystals, for example, in calcium pyrophosphate disease, a
typical bystander in OA can activate the inﬂammasome lead-
ing to interleukin-1 activation [8]. On the other hand,
during aging the immune system is less capable to resolve
inﬂammation in general. In other words, not only the
initiation of inﬂammation, but also the lack of inﬂammation
might be involved in OA, notably in the aged individual.
Notwithstanding, mechanical dysfunction is still regard-
edaskeyplayerinOApathogenesis,predominantlyinweight
bearing joints. This is also referred as “continuous loading
theory.” Apart from the aforementioned molecular impair-
ment of cartilage, also the musculature is involved in stabi-
lization and therefore protection of the joint. Muscle atrophy
is well recognized in OA pathogenesis [9]. In the elder-
ly, muscle atrophy is highly prevalent; this can be caused by
sarcopenia in general, lack of physical training, malnutrition
or arthrogenic muscle inhibition as a direct consequence of
OA.
Finally, aging leads to a reduced regenerative capacity,
for example, shown by the reduced levels of stem cells in
connective tissue in the elderly. The elderly enters a catabolic
state, where a presenescent cell state leads to subsequent loss
of connective tissue homeostasis.
Inthispaperwegiveanoverviewofage-relatedstructural
and functional changes occurring in the course of OA.
2. Changes inGaitBiomechanics inOA
Changes in the joint biomechanics of patients suﬀering
from OA have been shown in various studies. Gait analyses
showed that patients with OA in the medial compartment of
the knee walk with a more extended knee at heel strike [10].
Additionally, the external knee adduction moment has been
identiﬁed as an important factor in medial knee OA [10–12].
The peak knee adduction moment has been shown to
increase with increasing varus malalignment [12]a n dw i t h
increasing radiographic disease severity [10, 11]. Although
the knee adduction moment has been identiﬁed as a risk
factor for disease progression [11], there is also evidence
that in early stages of OA, patients are able to reduce the
knee adduction moment by moving the trunk laterally [10].
However, to achieve this, suﬃcient hip abduction muscle
strength is needed to balance the external hip adduction
moment.Journal of Aging Research 3
Inarecentmeta-analysis,Pietrosimoneetal.[13]showed
that patients with knee OA have a deﬁcit in the activation of
the quadriceps muscles. Additionally, there is evidence that
weak knee extensor increases the risk to develop sympto-
matic knee OA [14, 15]. The muscles surrounding the
knee joint are important for the stability. Muscle weakness
can therefore impair the neuromuscular protection of the
joint leading to microtraumas and possibly joint damage
[16]. Hence, muscular dysfunction might not only be a
consequence of the disease but could also play a role in the
development of OA [14, 16].
3. Biomechanical Changes in the Elderly
Walking speed is relatively consistent between age 20 and 70
and declines after age 70 [17, 18]. Older people often walk
with a reduced step length which is a possible adaptation
to lower muscle strength and fear of tripping and falling
[19, 20]. In this study it has been shown that patients with
knee OA produce lower knee extension forces than age-
matched controls. These force levels were comparable to
thoseofanonaverage20yearsolderagegroup.Incontrastto
thekneeOApatientsthatalsoshowedjointlaxity,thehealthy
elderly could maintain normal joint biomechanics during
walking by increasing the muscle activity. Additionally, aging
aﬀects the joint proprioception. In older subjects the joint
position sense was worse than in young ones. It was also seen
thatkneeOApatientshaveanevenworsejointpositionsense
than healthy elderly of a similar age. This could indicate that
the age-related decline in proprioception increases the risk
of OA due to reduced joint stability and increased joint stress
[21].
While some age-related changes in the gait pattern like
a reduced walking speed could be beneﬁcial in reducing the
risk or progression of OA [10], other changes, like muscle
weakness or reduced proprioception, could increase the risk
of OA, especially in the presence of additional factors such as
joint laxity or pain.
Obesity has a negative impact on biomechanics, at least
in weight bearing joints [22] and has been demonstrated as
a risk factor for OA in large studies [23]. Interestingly, the
negative eﬀect of obesity on cartilage decay is reversible. A
recent study postulated an improved cartilage quality in the
medial compartment in patients with knee OA after weight
loss [24]. In the elderly, obesity in combination with sar-
copenia is frequently encountered, a combination which
h a sf u r t h e rn e g a t i v ei n ﬂ u e n c eo nO A[ 25]. Whether obesity
causes sarcopenia in the elderly, or obesity is a consequen-
ce of reduced physical activity, remains a chicken-egg ques-
tion.
4.CartilageDecaywithAge
Progressive loss of articular cartilage is considered as the
hallmark of OA. Cartilage consists of chondrocytes that
are embedded in a specialized extracellular matrix (ECM),
which is composed of water, collagen II, and proteoglycans.
Chondrocytes are quiescent nondividing cells responsible for
the maintenance of cartilage homeostasis through a balanced
production of catabolic and anabolic factors. During aging,
senescence is induced either by progressive telomere short-
ening due to repeated cell division or environmental stress
factors, such as oxidative damage, chronic inﬂammation or
ultraviolet radiation [26]. Indeed, in vitro proliferation of
chondrocytes from young donors diﬀers dramatically from
aged and OA donors, due to a complete lack of cell division
in the latter [27]. However, as chondrocyte proliferation
is scarcely observed in normal or osteoarthritic cartilage,
telomere shortening is not regarded as the most likely mech-
anism for senescence [28]. Accumulation of oxidative dam-
age is considered as a major player in the induction of sen-
escence in chondrocytes. Decreased expression of oxygen
radical scavengers, such as superoxide dismutase, has been
demonstrated in OA cartilage [29] .T h e r ei sa m p l ee v i d e n c e
that age-dependent alterations in chondrocyte metabolism
or signal transduction associates with progression of OA
[30, 31].
These epigenetic-induced changes in chondrocytes skew
the balance that dictates cartilage homeostasis and induces
alterations of the ECM and cartilage integrity that promote
development of OA. Loss of biomechanical function of carti-
lage during aging has been associated with a decrease in gly-
cosaminoglycan content [32], which is normally deposited
by chondrocytes. Besides direct modulation of the ECM by
chondrocytes, age-related changes in ECM components has
been proposed to mediate cartilage decay. Age-dependent
accumulation and consequent cross-linking of advanced
glycation end products (AGE) in collagen has been shown to
increasecartilagestiﬀness, whichmakesit brittle andimpairs
its load-absorbing function [3]. Moreover, chondrocytes
express the receptor for AGE (RAGE) and engagement of
the receptor induces the production of cartilage-degrading
enzymes [33]. Together, age-related changes in chondrocytes
and components of ECM crucially impair the function of
cartilageanditscapacitytocopewithmechanicalorenviron-
mental stress factors, which is likely to predispose to OA
development (Table 1).
5 .S ubc h o nd ralBo neA d aptio ninA gingand
t h eR o l eo fBo n eM a s sinO A
The microarchitecture of the skeleton, notably the subchon-
dralbone,constantlyadaptstomechanicalloading.Mechan-
otransductionprocessesleadtobonemodelingandremodel-
ing.Impairedjointloadingpatternstriggerhighsubchondral
bone density, probably in order to avoid (micro) fractures
and to ensure minimal joint function. Subchondral density
can be accurately assessed by computed tomography osteo-
absorptiometry (CT-OAM) [34]. Figure 2 shows a tibial
plateau of a geriatric patient suﬀering from end stage knee
OA who underwent joint replacement.
Complete cartilage loss is seen on the medial side. Below,
CT-OAMwasperformed.Highestsubchondralbonemineral
density (BMD) indicated in red is observed in the region
of maximal cartilage damage. On a molecular level, mech-
anosensorsonosteoblastshavebeendiscoveredwhichinduce
interleukin-6 and -8 expression within subchondral bone
aﬀectedbyOAuponcyclicmechanicalstimulation[35].This4 Journal of Aging Research
Table 1: Age-related mechanisms triggering OA.
Mechanism Consequence
Oxidative stress Cell senescence
Apoptosis/autophagy Reduced regeneration capacity
Matrix protein modiﬁcation (e.g., glycosylation) Reduced elasticity, ﬂuid content, stability
Nonenzymatic collagen cross-linking Impaired crack-bridging potency
Sarcopenia Reduced joint stability
Loss of proprioception Microtrauma, Charcot-like arthropathy
Joint laxity Microtrauma
Synovitis Inﬂammatory cytokine production
Increased osteon density Bone stiﬀness
Reduced circulating progenitor cells (e.g., MSC) Impaired regeneration capacity
(a)
(b)
Figure 2: Tibial plateau of an elderly patient showing end-
stage OA with complete cartilage loss (a). Computed tomography
osteoabsorptiometry (CT-OAM) indicates high bone density in red
(b).
is in line with the observation that increased BMD measure-
ment of the knee correlates with clinical OA. However, the
relation between generalized bone loss or osteoporosis and
OA is still controversial. The MOST study has shown that
high femoral neck and whole-body BMD are associated with
an increased risk of OA [36]. However, osteophytes alter
BMD assessment, so it remains unclear whether increased
BMD is a consequence, rather than a cause of OA. Clearly,
the higher bone density in patients with OA is not associated
with a lower risk of vertebral or nonvertebral fractures [37].
6. Muscle Atrophy and Its Role on
OA in the Elderly
Muscle atrophy can have several causes. Immobilization,
malnutrition, myopathy, neurologic disorders, comorbidity
of several common diseases such as cancer, congestive heart
failure, COPD, or any state of chronic inﬂammation aﬀect
the muscle mass substantially. Also endocrinologic disorders
which are generally more frequently observed in the elderly
can trigger muscle atrophy, for example, low testosteron
levels, diabetes mellitus, or hypothyroidism.
In contrast to secondary muscle atrophy, the commonly
observed loss of muscle mass in the elderly is a syndrome
referred to as “sarcopenia” [38]. Reduced muscle tissue usu-
ally starts at the age of 50 years and results in diminished
muscle function. Subsequently, decreased muscle strength of
the joints contribute to the pathogenesis of OA within the
nextdecades.Fiftypercentofallindividualsagedover75suf-
fer from sarcopenia.
The mechanistic association between OA and muscle
atrophy has been clearly demonstrated. Several factors such
asreducedstability,jointimmobilization,restrictionofrange
of motion but also so called arthrogenous muscle inhibition
or reﬂex atrophy are implicated in this process. The latter
is due to abnormal nociceptive aﬀerent feedback processes,
releasing neuromodulators in the spinal cord, which in turn
cause a change in alpha-motoneuron excitability. In knee
OA, it has been shown that quadriceps muscle strength is
reduced between 20 and 40% for isometric and isokinetic
contractions [39].
7.PhysicalActivityPreventingOA
Physiotherapy is the gold standard for OA treatment. The
positive eﬀect of physiotherapy on knee OA has been clearlyJournal of Aging Research 5
demonstrated by a meta-analysis of 32 controlled trials
[40]. Furthermore, physical activity seems to have preventive
eﬀects on OA. A consensus stating that performing struc-
tured strengthening exercises has a favorable eﬀect on pain
and functioning in sedentary patients with knee OA has
been formulated by several organisations, for example, by
the MOVE consensus [41]. In ﬁrst line, physical activity in
OA patients encounters clinical or subclinical muscle atro-
phy which has implications on joint stability [42], but also
stimulates weight reduction [43].
8. The Role of Immunosenescence inOA
In the last decade, inﬂammation in OA has attracted increas-
ing interest. A growing arsenal of anti-inﬂammatory com-
pounds now is available which successfully works in inﬂam-
matory arthritis. On the search for disease modifying osteo-
arthritis drugs (DMOADs), some of those compounds have
also been successfully applied to OA, at least in case reports
or case series [44]. Inﬂammation in OA is often encountered
clinically by swelling of the joint, redness and night pain.
This “disease activation” in OA typically occurs in episodes,
either resolving spontaneously, or sometimes by the intra-
articular injection of steroids [45]. The eﬃcacy of steroids in
a c t i v a t e dO Ai sw e l ld o c u m e n t e da n ds a f e ,i fa p p l i e du n d e r
sterile conditions and in right intervals.
Synovial inﬁltration by inﬂammatory cells such as
macrophages, mast cells or lymphocytes occurs in around
50% of the patients [6]. In MRI studies, synovitis shown
with or without contrast agent correlates with pain and also
radiological progression of OA. The inﬂammatory status of
the joint is also reﬂected by increased pro-inﬂammatory
cytokine levels such as TNF-alpha or IL-1 [46]. This is likely
a result of the inﬂammatory cell inﬁltration in the joint
and mast cell activation. Interestingly, recent ﬁndings indi-
cate that mast cells, but also subchondral osteoblasts express
mechanoreceptors which change their expression pattern
upon mechanical stimulation, for example, by the expres-
sion of IL-8 [35]. But also synovial ﬁbroblasts and even
chondrocytes produce more proinﬂammatory cytokines and
participate in inﬂammation.
In animal models, it has been shown that exercise leads
to an increased expression of interleukin-10 in the joint [47].
IL-10 is a strong anti-inﬂammatory mediator and therefore
likely implicated in the resolution of mechanically induced
inﬂammation or irritation (Figure 3).
Immunosenescence is characterized by a reduced capac-
ity of immune cells to encounter antigens and resolution of
inﬂammation.
Recentdatashowedthatphysicalactivityindeedcounter-
actsimmunoscenesence[48].Althoughtheexactmechanism
is still unclear, exercise impacts multiple aspects of the
immune response including T-cell phenotype, T-cell pro-
liferation, and as for IL-10, cytokine expression [49].
9.CellRenewalandStemCellCapacityinOA
Cartilagehasalowregenerationcapacityduetolackofviable
progenitor cells. Mesenchymal stem cells are postulated to
IL-1
IL-6
TNF
IL-10 Physical
activity
OA
Inﬂammatory Anti-inﬂammatory
Figure 3: Cytokine expression at rest and during physical activity.
OA: osteoarthritis, IL: interleukin, TNF: tumor necrosis factor.
be involved in connective tissue homeostasis and repair. The
failure of repair mechanisms in connective tissues in OA is
compelling.Indeed,reducednumbersofmultipotentmesen-
chymal progenitor CD105+/CD166+ cells have been detect-
ed in the elderly. Furthermore, a lower number and lower
chondrogenic and osteogenic diﬀerentiation capacity in pro-
genitors cells from aged individuals have been demonstrated
[50, 51]. Multipotent stem cells were also isolated from
humancruciateligamentssuggestingtheirregenerativecapa-
city also occurring in ligament structures [52]. Increased
numbers of MCS are seen in the synovial ﬂuid of patients
with OA indicating a biological response [53]. These obser-
vations open the way for new therapeutic options notably
in the elderly by applying those cells in the joints. Current
studies investigate the possibility to obtain autologous MSC
from synovial tissue in OA patients [54]. On the other hand,
MSCcanbeobtainedfromothertissue,forexample,adipose
tissue. Notwithstanding, controlled clinical trials showing a
clear eﬃcacy of MSC treatment in OA, are still lacking.
10. Conclusion
Aging altersthe humanmusculoskeletal systemon a molecu-
lar and functional levels. Cellular renewal, matrix modiﬁca-
tion,andimmunosenescenceaﬀecttheregenerationcapacity
of connective tissue in general, but notably of bone and
cartilage. This explains the important role of aging in the
development and progression of OA. On the other side,
several features observed during aging such as muscle atro-
phy, BMD, and inﬂammation are potentially reversible and
should be counteracted, regardless of age.
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